Current Opinion in Gastroenterology was launched in 1985. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of gastroenterology is divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Editor and the Section Editors for this issue.
Daniel K. Podolsky, MD
Daniel K. Podolsky is Mallinckrodt Professor of Medicine at the Harvard Medical School and Chief of Gastroenterology at Massachusetts General Hospital. Dr. Podolsky received both his undergraduate and medical degrees from Harvard Medical School, followed by residency training in Internal Medicine, and fellowship in Gastroenterology at Massachusetts General Hospital. He joined the faculty of Harvard Medical School and the staff of Massachusetts General Hospital in 1981. Since 1995 he has served as Mallinckrodt Professor of Medicine at Harvard Medical School. In 1989 Dr. Podolsky was appointed Chief of Gastroenterology at Massachusetts General Hospital and since then has overseen a dynamic program of research and training in addition to a comprehensive program of clinical care in gastroenterology. In 1991, Dr. Podolsky established a multidisciplinary Center for the Study of Inflammatory Bowel Disease funded through the NIDDK Digestive Disease Center program.
He is author of more than 300 original research and review articles. Dr. Podolsky has also mentored over 75 post doctoral research fellows who are now advancing the field of gastroenterology. He is the past editor-in-chief of the journal Gastroenterology and has served an active role in a number of national organizations and is Immediate Past-President of the American Gastroenterological Association.
Edgar C. Boedeker, MD
Dr. Boedeker graduated from Harvard College and received his medical degree from Washington University School of Medicine (St. Louis). After residency in internal medicine at Barnes Hospital/Washington University, he trained in gastroenterology at Boston University, then returned to Washington University for a year as Assistant Director of the General Medicine Service (Chief Resident). From 1974 to 1994, Dr. Boedeker was chief of Gastroenterology at the Walter Reed Army Institute of Research, (Washington D.C.) where he directed a laboratory program focused on pathogenesis and vaccine development for enterotoxigenic E. coli, the major cause of traveler's diarrhea. During this time he rose from Assistant Professor to Professor of Medicine at the Uniformed Services University of the Health Sciences. Since 1994 Dr. Boedeker has been Professor of Medicine (gastroenterology) at the University of Maryland School of Medicine in Baltimore, and head of the Gut/Pathogen Interaction Laboratory at the Center for Vaccine Development.
Robert S. Bresalier, MD
Robert S. Bresalier, MD, is currently Professor of Medicine (with tenure) and Chairman of the Department of Gastrointestinal Medicine and Nutrition at the University of Texas MD Anderson Cancer Center, and holds the Birdie J. and Lydia J. Resoft Distinguished Professorship in Gastrointestinal Oncology at that institution. He received his medical degree from the University of Chicago, trained in Internal Medicine at Washington University School of Medicine and Gastroenterology at the University of California San Francisco, where he was a faculty member for many years. He was formerly Director of Gastrointestinal Oncology at Henry Ford Health Sciences Center and a faculty member at the University of Michigan. Dr. Bresalier is an internationally recognized expert and investigator in several areas of Gastroenterology including Gastrointestinal Oncology and Acid Related Disorders. He has been a leading investigator in the area of gastrointestinal tumor biology, and specifically the role of glycoproteins and carbohydrate binding proteins in tumor progression and metastasis. In addition to longstanding NIH funding for this work, he leads active NIH funded research programs in cancer screening, early detection, and prevention. He is a member of the editorial board of numerous journals, including Gastroenterology, Cancer (Associate Editor), Current Opinion in Gastroenterology (Section Editor), Current Treatment Options in Gastroenterology (Section Editor), Cancer and Metastasis Reviews (Section Editor), Clinical and Experimental Metastasis, and others. He is also the author of over 200 articles, chapters and reviews. Dr. Bresalier has served on numerous advisory boards, including National Institute of Health advisory boards and study sections and the Michigan Cancer Consortium, and was Chairman of the Colon Cancer Group for the NIH sponsored Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial for 11 years. He has also been a frequent invited speaker and participant in national and international symposia on gastrointestinal cancer, including the prestigious Keystone and Falk symposia and NIH workshops on tumor biology. He is currently Vice-Chair of the Oncology section of the American Gastroenterological Association.